TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
A randomized, controlled, open-label multicenter trial to assess the safety and efficacy of 3
oxaliplatin-fluoropyrimidine containing regimens (mFOLFOX6; bFOL; XELOX) + Bevacizumab (TREE1
and TREE2) as first line therapy of advanced metastatic colorectal cancer.